Browse by Poster Presenter

Skip to main content

CTOS 2025 Main banner

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

I
Iafrate, A John

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
A John Iafrate
Favorite
Ibanez Sanchez, Glorife

Memorial Sloan Kettering Cancer Center
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Glorife Ibanez Sanchez
Favorite
Ibanez Sanchez, Glorymar

Memorial Sloan Kettering Cancer Center
(P 22) SINGLE CELL SEQUENCING ENABLES LINEAGE-INFORMED TARGETING OF OSTEOSARCOMA
Glorymar Ibanez Sanchez
Favorite
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Glorymar Ibanez Sanchez
Favorite
Ibrahim, Minas

Medical University of Vienna
(P 86) CARBON FIBRE-REINFORCED PEEK IMPLANTS FOR TUMORS OF THE SPINE
Minas Ibrahim
Favorite
Ibrahim, Toni

IRCCS Istituto Ortopedico Rizzoli
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Toni Ibrahim
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Toni Ibrahim
Favorite
Iglesias, Antía

Hospital La Princesa
(P 356) DESMOID TUMORS: A RETROSPECTIVE ANALYSIS FROM A REFERRAL CENTER
Antía Iglesias
Favorite
Ignazzi, Gianluca

Italian Sarcoma Group ISG ETS
(P 210) TOWARDS INTERNATIONALIZATION OF THE CLINICAL RESEARCH COORDINATOR ROLE: THE FIRST DROP OF THE NIAGARA FALLS PROJECT
Gianluca Ignazzi
Favorite
Ikeuchi, Kyoko

Hyogo Cancer Center
(P 192) OPTIMAL DOSING SCHEDULE OF SUNITINIB BASED ON PLATELET COUNT IN AN OLDER PATIENT WITH GASTROINTESTINAL STROMAL TUMOR
Kyoko Ikeuchi
Favorite
Imamura, Jarrell

Cleveland Clinic Research
(P 10) COLLATERAL SENSITIVIES EMERGE DURING THE EVOLUTION OF CHEMORESISTANCE TO MAP CHEMOTHERAPY IN OSTEOSARCOMA
Jarrell Imamura
Favorite
Ingram, Davis

MD Anderson Cancer Center
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Davis Ingram
Favorite
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Davis Ingram
Favorite
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Davis Ingram
Favorite
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Davis Ingram
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Davis Ingram
Favorite
(P 411) TFCP2 FUSION-POSITVE RHABDOMYOSARCOMAS: A REPORT OF 10 CASES AND A REVIEW OF THE LITERATURE
Davis Ingram
Favorite
Ioakeim-Ioannidou, Myrsini

Massachusetts General Hospital
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Myrsini Ioakeim-Ioannidou
Favorite
(P 461) A RETROSPECTIVE ANALYSIS OF PATIENTS WITH CONVENTIONAL CHORDOMA TREATED WITH SYSTEMIC THERAPY
Myrsini Ioakeim-Ioannidou
Favorite
Iranpur, Khurshid

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Khurshid Iranpur
Favorite
Ireland, Beth

Adaptimmune
(P 337) POOLED ANALYSIS OF TRABECTEDIN EFFICACY IN MYXOID/ROUND CELL LIPOSARCOMA FROM THREE PROSPECTIVE CLINICAL TRIALS
Beth Ireland
Favorite
Irvin, Boston

University of Miami School of Medicine
(P 320) CLINICAL CHARACTERISTICS AND RECURRENCE PATTERNS IN HISPANIC VS. NON-HISPANIC PATIENTS WITH LEIOMYOSARCOMA: FINDINGS FROM A RETROSPECTIVE SINGLE-CENTER COHORT STUDY
Boston Irvin
Favorite
(P 327) INITIAL TREATMENT MODALITY AND RECURRENCE IN NON-METASTATIC LEIOMYOSARCOMA: A RETROSPECTIVE COHORT STUDY
Boston Irvin
Favorite
Isaacson, Alexandra

University of Iowa Health Care
(P 370) CLINICAL OUTCOMES OF CUTANEOUS UNDIFFERENTIATED PLEOMORPHIC SARCOMA AND SUBCUTANEOUS MYXOFIBROSARCOMA: A RETROSPECTIVE REVIEW
Alexandra Isaacson
Favorite
Isakoff, MIchael

Connecticut Childrens
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
MIchael Isakoff
Favorite
Ismail, Nur Nadiah

National University of Singapore
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Nur Nadiah Ismail
Favorite
Isobe, Kiyotaka

Department of Pediatric Oncology, National Cancer Center Hospital
(P 271) SAFETY AND EFFICACY OF CABOZANTINIB IN PEDIATRIC PATIENTS WITH MALIGNANT SOLID TUMORS (CAMEL TRIAL/NCCH2106): A SINGLE-CENTRE PHASE I TRIAL
Kiyotaka Isobe
Favorite
Istl, Alexandra

Medical College of Wisconsin
(P 329) LAPAROSCOPY-ASSISTED PERCUTANEOUS CRYOABLATION FOR THE TREATMENT OF ABDOMINAL WALL DESMOID TUMORS
Alexandra Istl
Favorite
Italiano, Antoine

Department of Medicine, Institut Bergonié
(P 42) PRECLINICAL VALIDATION OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, AND EPIGENETIC SENSITIZATION STRATEGIES IN SOFT TISSUE SARCOMAS
Antoine Italiano
Favorite
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
Antoine Italiano
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Antoine Italiano
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Antoine Italiano
Favorite
(P 434) A FIRST-IN-HUMAN PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS
Antoine Italiano
Favorite
(P 445) TEADES PH1/2 STUDY WITH ODM-212: PRELIMINARY RESULTS IN EHE PATIENTS
Antoine Italiano
Favorite
Itkin, Boris

SQCCCRC
(P 56) COMPARISON OF PATHOGENIC AND LIKELY PATHOGENIC VARIANTS DISTINCT FROM SPECIFIC DRIVERS IN DIFFERENT SARCOMA GROUPS
Boris Itkin
Favorite
Ito, Kan

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Kan Ito
Favorite
Iuliani, Michele

Fondazione Policlinico Universitario Campus Bio-Medico
(P 61) HER2 TARGETING IN CHORDOMA: PRECLINICAL INSIGHTS ON TRASTUZUMAB DERUXTECAN
Michele Iuliani
Favorite
Iwata, Shintaro

National Cancer Center Hospital Japan
(P 79) AGE-BASED TREATMENT PATTERNS AND OUTCOMES OF LOCALIZED HIGH-GRADE OSTEOSARCOMA FROM A NATIONWIDE DATABASE: WHAT IS THE OPTIMAL STRATEGY FOR PATIENTS OLDER THAN 40 YEARS?
Shintaro Iwata
Favorite
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Shintaro Iwata
Favorite
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Shintaro Iwata
Favorite
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Shintaro Iwata
Favorite
Iwenofu, O. Hans

The Ohio State University Wexner Medical Center
(P 153) DOES THE QUANTITY OF DEDIFFERENTIATION MATTER IN THE CLINICAL OUTCOMES OF DEDIFFERENTIATED CHONDROSARCOMA? A 10-YEAR SINGLE TERTIARY INSTITUTIONAL EXPERIENCE OF A SERIES.
O. Hans Iwenofu
Favorite
Iyer, Aditya Venkat

Green hope high school
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Aditya Venkat Iyer
Favorite
Iyer, Sowmya

Broad Institute
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Sowmya Iyer
Favorite